Use of Santyl in Diabetic Foot Ulcers
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.
Also called NCT02581488
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 102 participants
- Sponsor
- Smith & Nephew, Inc.
- Registry
-
NCT02581488
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02581488. Randomized; no masking; primary purpose treatment. Start 2015-10 (actual); primary completion 2017-01-12 (actual). Results posted on 2018-08-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Use of Santyl in Diabetic Foot Ulcers
- Condition
- Diabetic Foot
- Condition
- Foot Ulcer, Diabetic
- Intervention (Biological)
- Santyl
- Intervention (Other)
- Product containing silver
- Lead sponsor
- Smith & Nephew, Inc.
Record details
- Record id
cardio:ct-nct02581488- Content hash
90119d4027cb22a6799f43defdc443c9ac3eb45e0db78aae2630ff7ecb6e9efd